MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 112 filers reported holding MIRATI THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $703,000 | +33.9% | 6,826 | -4.7% | 0.00% | +100.0% |
| Q1 2019 | $525,000 | +71.6% | 7,164 | -0.8% | 0.00% | 0.0% |
| Q4 2018 | $306,000 | -7.8% | 7,222 | +2.5% | 0.00% | 0.0% |
| Q3 2018 | $332,000 | +32.8% | 7,049 | +38.8% | 0.00% | 0.0% |
| Q2 2018 | $250,000 | – | 5,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |